Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Businesses Defend Use of Biometrics Amid Facial-Recognition Backlash
May 23, 2019
“Some companies that use biometric technology worry that the growing backlash against the use of facial recognition for law enforcement could negatively affect their businesses. Facial recognition can be used for applications such as aiding medical diagnosis, validating bank accounts, monitoring drivers for alertness, tracking retail customers for marketing insights and monitoring crowds for safety.”
The Wall Street Journal article addresses the growing controversy over facial recognition technologies, focusing on FDNA’s Face2Gene. Unlike commercial applications, Face2Gene employs AI to analyze facial features for diagnosing genetic disorders, highlighting its vital role in healthcare. FDNA defends its use, emphasizing the technology’s potential to improve diagnostic accuracy and enable early intervention for rare conditions.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…